Close Menu

NEW YORK (360Dx) – Netscientific said today that its portfolio company ProAxsis has signed a licensing agreement with Queen's University of Belfast for the university's ProteaseTag technology.

The deal gives ProAxsis exclusive intellectual property rights to the technology, which enables the measurement of active protease biomarkers. It is the second licensing agreement ProAxsis has signed with Queens for the technology. The first was established when the company spun out of the university in 2013.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.